PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-51.66%
Negative revenue growth while MTDR stands at 2.32%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-93.69%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-226.72%
Negative EBIT growth while MTDR is at 0.58%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-226.72%
Negative operating income growth while MTDR is at 0.58%. Joel Greenblatt would press for urgent turnaround measures.
-58.58%
Negative net income growth while MTDR stands at 1.67%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-57.78%
Negative EPS growth while MTDR is at 8.73%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-58.74%
Negative diluted EPS growth while MTDR is at 8.73%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
0.51%
Share reduction more than 1.5x MTDR's 7.90%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
No Data
No Data available this quarter, please select a different quarter.
-15.81%
Dividend reduction while MTDR stands at 0.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
-47.13%
Negative OCF growth while MTDR is at 70.18%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
34.65%
FCF growth above 1.5x MTDR's 7.81%. David Dodd would verify if the firm’s strategic investments yield superior returns.
-90.63%
Negative 10Y revenue/share CAGR while MTDR stands at 178.47%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-84.06%
Negative 5Y CAGR while MTDR stands at 0.44%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-84.05%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
-96.50%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
-92.50%
Negative 5Y OCF/share CAGR while MTDR is at 113.15%. Joel Greenblatt would question the firm’s operational model or cost structure.
-86.97%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
-127.28%
Both face negative decade-long net income/share CAGR. Martin Whitman would suspect a shrinking or highly disrupted sector.
-397.03%
Both exhibit negative net income/share growth over five years. Martin Whitman would suspect a challenging environment for the entire niche.
-171.59%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
-73.41%
Negative equity/share CAGR over 10 years while MTDR stands at 0.00%. Joel Greenblatt sees a fundamental red flag unless the competitor also struggles.
-74.88%
Both show negative equity/share growth mid-term. Martin Whitman suspects cyclical or structural challenges for each company.
-19.61%
Both show negative short-term equity/share CAGR. Martin Whitman suspects an industry slump or unprofitable expansions for both players.
-86.86%
Both reduced dividends long-term. Martin Whitman might check if sector-level headwinds forced universal cuts.
-93.49%
Both lowered dividends mid-term. Martin Whitman might suspect broad sector constraints or strategic shifts from dividends.
-91.14%
Negative near-term dividend growth while MTDR invests at 0.00%. Joel Greenblatt sees a weaker short-term distribution policy unless justified by strategic spending.
3.27%
AR growth is negative/stable vs. MTDR's 33.17%, indicating tighter credit discipline. David Dodd confirms it doesn't hamper actual sales.
No Data
No Data available this quarter, please select a different quarter.
-1.82%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
-11.31%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
3.77%
Debt growth far above MTDR's 0.07%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
-12.36%
We cut SG&A while MTDR invests at 0.26%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.